Search Results - Xiaoteng Zou

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Corrigendum to "Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis" [Pharmacol. Res. 188 (2023) 106668] by Tianyao Lei, Tianwei Xu, Niu Zhang, Xiaoteng Zou, Ziyue Kong, Chenchen Wei, Zhaoxia Wang

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: